Association of Postangioplasty Femoropopliteal Dissections With Outcomes After Drug-Coated Balloon Angioplasty in the Femoropopliteal Arteries

被引:15
|
作者
Giannopoulos, Stefanos [1 ]
Strobel, Aaron [1 ]
Rudofker, Eric [1 ]
Kovach, Christopher [1 ]
Schneider, Peter A. [2 ]
Armstrong, Ehrin J. [1 ]
机构
[1] Univ Colorado, Rocky Mt Reg VA Med Ctr, Div Cardiol, Denver, CO 80202 USA
[2] Univ Calif San Francisco, Div Vasc & Endovasc Surg, San Francisco, CA 94143 USA
关键词
dissection; endovascular therapy; drug-coated balloon; paclitaxel coated balloon; peripheral artery disease; LOWER-EXTREMITY; ENDOVASCULAR INTERVENTIONS; TASK-FORCE; DISEASE; MANAGEMENT; CALCIFICATION; CONSENSUS; PATTERNS; SURGERY; IMPACT;
D O I
10.1177/15266028211016441
中图分类号
R61 [外科手术学];
学科分类号
摘要
Purpose: Balloon angioplasty for the treatment of femoropopliteal lesions is often complicated by postangioplasty dissections. While dissections are known to affect patency and reintervention after balloon angioplasty, the association between dissections and major adverse limb event (MALE) after drug-coated balloon (DCB) angioplasty remains uncertain. Thus, the postangioplasty dissection and bailout stenting patterns were investigated. Materials and Methods: This was a single-center retrospective study enrolling patients with de novo femoropopliteal lesions treated with DCB with/without stenting. Postangioplasty target vessel dissection was graded based to the coronary artery classification grades A-F, with grade C-F considered "severe." Cox regression analysis was performed to examine the association of dissection severity with outcomes during 2-year follow up, among nonstented cases. Results: In 85.3% of the cases (N=203/238) a postangioplasty dissection was observed. The average dissection length was 55.57 mm (SD 36.71 mm), with 1 dissection present in 91.8% (N=180/196) and 2 or more dissections present in 8.2% (N=16/196). Dissection severity was grade A (19.8%), B (20.6%), C (23.1%), D (10.9%), E (10.1%), and F (0.8%). Bailout stenting was required in 40.4% of the patients, being more prevalent among grade C and grade E cases. Among 142 nonstented cases, dissections were present in 85.2%. A total of 75 (52.8%) of these dissections were grade A and B, while 46 (32.4%) were grade C to F. Among nonstented cases, grade C (hazard ratio [HR] 5.83; 95% CI 1.25 to 27.31; p=0.025) and grade D (HR 6.32; 95% CI 1.39 to 28.86; p=0.017) vs grade A dissections were associated with a higher risk for 2-year MALE. Multivariate analysis adjusting for several lesion characteristics demonstrated a statistically significant higher risk for 2-year MALE among the severe dissection group (HR 2.94; 95% CI 1.27 to 6.79; p = 0.012). Interestingly, the risks of limb loss (HR 1.30; 95% CI 0.22 to 7.79; p=0.774) and repeat revascularization (HR 0.95; 95% CI 0.40 to 2.26; p=0.905) during follow-up were similar between the 2 groups. Conclusion: This study indicated that nonstented moderate and severe postangioplasty dissections after DCB angioplasty were associated with higher risk for MALE. Future studies are needed to validate our results and determine other dissection characteristics (eg, total dissection length, lumen area, total number of dissections) that may affect the efficacy of DCB.
引用
收藏
页码:593 / 603
页数:11
相关论文
共 50 条
  • [41] Efficacy of Rotational Atherectomy Followed by Drug-coated Balloon Angioplasty for the Treatment of Femoropopliteal Lesions-Comparison with Sole Drug-coated Balloon Revascularization: Two-year Outcomes
    Rodoplu, Orhan
    Oztas, Didem Melis
    Meric, Mert
    Beyaz, Metin Onur
    Ulukan, Mustafa Ozer
    Yildiz, Cenk Eray
    Unal, Orcun
    Ugurlucan, Murat
    ANNALS OF VASCULAR SURGERY, 2021, 73 : 222 - 233
  • [42] Health Care Utilization Following Inpatient Femoropopliteal Revascularization With Drug-Coated Balloon Angioplasty: A Nationwide Cohort Analysis
    Gurin, Michael, I
    Beyer, Sebastian E.
    Weinberg, Mitchell
    Parikh, Sahil A.
    Armstrong, Ehrin J.
    Albaghdadi, Mazen S.
    Aronow, Herbert D.
    Carroll, Brett J.
    Yeh, Robert
    Secemsky, Eric A.
    JOURNAL OF ENDOVASCULAR THERAPY, 2021, 28 (02) : 246 - 254
  • [43] Factors associated with recurrence after drug-coated balloon therapy for femoropopliteal in-stent restenosis
    Kurata, Naoya
    Iida, Osamu
    Asai, Mitsutoshi
    Okamoto, Shin
    Ishihara, Takayuki
    Nanto, Kiyonori
    Tsujimura, Takuya
    Hata, Yosuke
    Toyoshima, Taku
    Higashino, Naoko
    Mano, Toshiaki
    Masai, Takufumi
    Higuchi, Yoshiharu
    HEART AND VESSELS, 2024, : 461 - 470
  • [44] Safety and efficacy of paclitaxel drug-coated balloon in femoropopliteal in-stent restenosis
    Anantha-Narayanan, Mahesh
    Love, Keith
    Nagpal, Sameer
    Sheikh, Azfar Bilal
    Regan, Christopher J.
    Mena-Hurtado, Carlos
    EXPERT REVIEW OF MEDICAL DEVICES, 2020, 17 (06) : 533 - 539
  • [45] Atherectomy plus drug-coated balloon versus drug-coated balloon only for treatment of femoropopliteal artery lesions: A systematic review and meta-analysis
    Lin, Feng
    Wang, Haoran
    Ding, Wenjie
    Chen, Gan
    Zhang, Zhigong
    VASCULAR, 2021, 29 (06) : 883 - 896
  • [46] Impact of post-procedural peripheral fractional flow reserve after drug-coated balloon angioplasty in femoropopliteal lesions
    Iwasaki, Yoshihiro
    Shimada, Takenobu
    Koike, Jumpei
    Funatsu, Atsushi
    Kobayashi, Tomoko
    Ikeda, Takanori
    Nakamura, Shigeru
    CARDIOVASCULAR REVASCULARIZATION MEDICINE, 2024, 66 : 51 - 55
  • [47] Angiographic patterns of restenosis after drug-coated balloon angioplasty for femoropopliteal lesions and 1-year prognosis after repeat endovascular therapy
    Higashino, Naoko
    Iida, Osamu
    Ishihara, Takayuki
    Hata, Yosuke
    Toyoshima, Taku
    Tsukizawa, Tomofumi
    Nishian, Kunihiko
    Fujihara, Masahiko
    Kawasaki, Daizo
    Mano, Toshiaki
    CATHETERIZATION AND CARDIOVASCULAR INTERVENTIONS, 2023, 102 (06) : 1114 - 1121
  • [48] Systematic review and updated meta-analysis of the use of drug-coated balloon angioplasty versus plain old balloon angioplasty for femoropopliteal arterial disease
    Caradu, Caroline
    Lakhlifi, Emilie
    Colacchio, Elda Chiara
    Midy, Dominique
    Berard, Xavier
    Poirier, Mathieu
    Ducasse, Eric
    JOURNAL OF VASCULAR SURGERY, 2019, 70 (03) : 981 - +
  • [49] The Ranger drug-coated balloon: advances in drug-coated technology for treatment of femoropopliteal segment arterial disease
    Sharma, Navneet
    Finn, Matthew T.
    Parikh, Sahil A.
    Granada, Juan
    FUTURE CARDIOLOGY, 2023, 19 (03) : 127 - 135
  • [50] Clinical outcome of low-dose and high-dose drug-coated balloon angioplasty with intraplaque wiring for femoropopliteal chronic total occlusion lesions
    Shima, Yuki
    Taninobu, Narumi
    Ikuta, Akihiro
    Mushiake, Kazunori
    Tanaka, Hiroyuki
    Kadota, Kazushige
    CARDIOVASCULAR INTERVENTION AND THERAPEUTICS, 2025, 40 (02) : 337 - 343